SigmaR Life Science Launches Genetically Modified Human Cell Lines
Modified Human Cell Lines for Breast Cancer Research. The CompoZr® ZFN-modified breast cancer cell lines will accelerate drug discovery and enhance basic research. Published the Friday 29 of July of 2011 | Read more |
Skyline Diagnostics establishes Research Collaboration with Janssen
Skyline, using its proprietary knowledge and technologies will work with Janssen to generate and analyze diagnostic information related to the use of an undisclosed, marketed compound. Published the Friday 08 of July of 2011 | Read more |
 |
 |
Roche Diagnostics Supports European Union’s DETECTIVE Project
Project to Reduce Animal Testing. Published the Tuesday 21 of June of 2011 | Read more |
Separating ELA from the Crowd
Inaugural Advances in Separation Technology Conference to Join Streams at ELA. Published the Monday 06 of June of 2011 | Read more |
|
|
Maybridge Scientists to Exhibit Fragment Collections and Present Research Poster
Thermo Fisher Scientific Will Highlight Maybridge Fragment-Based Drug Discovery Solutions at Fragments III. Published the Wednesday 02 of March of 2011 | Read more |
Winner Eppendorf & Science Prize for Neurobiology 2010
It has been awarded to the Canadian scientist, Dr. Christopher Gregg, Postdoctoral Fellow at Harvard University for his research on maternal and paternal gene expression in the brain. Published the Tuesday 14 of December of 2010 | Read more |
|
|
Horizon Discovery to Support 50 Centers of Excellence in Human Cellular Gene-Editing
Company will provide open access to its rAAV GENESIS human gene-editing platform as part of strategy to generate 2500 new in vitro models of cancer, neurodegenerative cardiovascular and infectious diseases. Published the Tuesday 14 of December of 2010 | Read more |
Biomarkers Consortium Announcement
The Biomarkers Consortium Announces Availability of Alzheimer’s Disease Plasma Proteomics Data. Published the Thursday 09 of December of 2010 | Read more |
|
|
OGT Announces Major Role in Large Scale Diabetes Study
Genefficiency™ aCGH microarray service to process extensive sample set linking CNVs to disease susceptibility . Published the Thursday 02 of December of 2010 | Read more |
Tecan’s Freedom EVO® automates tropical disease research
The Clinical Pharmacology Department in the Mahidol-Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand, has chosen Tecan’s Freedom EVO® platform. Published the Tuesday 28 of September of 2010 | Read more |
|
|
PROSTATE CANCER
NEW PREDICTIVE & THERAPEUTIC OPTIONS WITH TRAIL Published the Tuesday 28 of September of 2010 | Read more |
Immutep announces final results in phase I/II chemoimmunotherapy trial
Clinical research paper describes IMP321’s potency in achieving clinical benefit in 90 per cent of patients, combined with paclitaxel in first-line metastatic breast cancer. Published the Wednesday 08 of September of 2010 | Read more |
|
|
European collaborative research to develop lab-on-chip system
System for cheap and fast cancer diagnosis Published the Thursday 02 of September of 2010 | Read more |
GTP Technology introduces improvements in continuous fermentation processes L. lactis
Enhancements to induced expression and an improved constitutive promoter open way for increased use of L. lactis in biologic, diagnostic, and cosmetic applications. Published the Thursday 22 of July of 2010 | Read more |
|
First page | Last page | 1 2 Next
|
|
Español 
English
